Aspen Aerogels, Inc. (NYSE:ASPN) Receives $19.00 Consensus Price Target from Analysts

Aspen Aerogels, Inc. (NYSE:ASPN) has received a consensus recommendation of “Buy” from the five brokerages that are covering the company, Marketbeat reports. Five investment analysts have rated the stock with a buy rating. The average 1 year price target among brokerages that have issued ratings on the stock in the last year is $19.00.

ASPN has been the topic of a number of recent research reports. HC Wainwright reaffirmed a “buy” rating and issued a $20.00 price objective on shares of Aspen Aerogels in a research note on Wednesday, February 14th. Roth Mkm initiated coverage on shares of Aspen Aerogels in a research note on Wednesday, March 6th. They issued a “buy” rating and a $22.00 price objective on the stock. Canaccord Genuity Group raised their price objective on shares of Aspen Aerogels from $13.00 to $17.00 and gave the company a “buy” rating in a research note on Wednesday, December 27th. TheStreet raised shares of Aspen Aerogels from a “d+” rating to a “c-” rating in a research note on Wednesday, March 6th. Finally, Canaccord Genuity Group raised their price target on shares of Aspen Aerogels from $13.00 to $17.00 and gave the company a “buy” rating in a research report on Wednesday, December 27th.

Aspen Aerogels Price Performance

ASPN stock opened at $17.62 on Tuesday. The company has a 50 day simple moving average of $15.00 and a 200 day simple moving average of $11.98. The stock has a market cap of $1.35 billion, a price-to-earnings ratio of -26.70 and a beta of 2.03. Aspen Aerogels has a 1 year low of $5.32 and a 1 year high of $19.10. The company has a debt-to-equity ratio of 0.24, a current ratio of 3.41 and a quick ratio of 2.91.

Aspen Aerogels (NYSE:ASPN) last announced its quarterly earnings results on Tuesday, February 13th. The construction company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.12) by $0.11. Aspen Aerogels had a negative net margin of 19.19% and a negative return on equity of 10.47%. The firm had revenue of $84.22 million during the quarter, compared to analysts’ expectations of $83.82 million. During the same period in the prior year, the company posted ($0.20) EPS. Research analysts anticipate that Aspen Aerogels will post -0.24 EPS for the current fiscal year.

Hedge Funds Weigh In On Aspen Aerogels

A number of large investors have recently modified their holdings of the company. Rice Hall James & Associates LLC lifted its position in Aspen Aerogels by 385.0% during the third quarter. Rice Hall James & Associates LLC now owns 623,135 shares of the construction company’s stock valued at $5,359,000 after purchasing an additional 494,662 shares during the last quarter. Silvercrest Asset Management Group LLC lifted its holdings in shares of Aspen Aerogels by 13.7% in the 2nd quarter. Silvercrest Asset Management Group LLC now owns 323,802 shares of the construction company’s stock worth $2,555,000 after acquiring an additional 38,986 shares during the last quarter. Principal Financial Group Inc. bought a new stake in shares of Aspen Aerogels in the 3rd quarter worth approximately $449,000. Maven Securities LTD bought a new stake in shares of Aspen Aerogels in the 3rd quarter worth approximately $860,000. Finally, Worth Venture Partners LLC bought a new stake in shares of Aspen Aerogels in the 3rd quarter worth approximately $3,684,000. 97.64% of the stock is currently owned by institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.